Tonghua Golden-horse Pharmaceutical Industry Co., Ltd. (000766.SZ) announced on July 24th that the company recently discovered the "Acceptance Notice" issued by the National Medical Products Administration for the application registration of Huperzine A eight hydrogen ammonia pyridine.
Huperzine A eight hydrogen ammonia pyridine is the active pharmaceutical ingredient of Huperzine A eight hydrogen ammonia pyridine tablets, which our company has independent intellectual property rights for. Huperzine A eight hydrogen ammonia pyridine tablets are a new type I national-level innovative drug with completely independent intellectual property rights developed by our company. It is a new type of acetylcholinesterase inhibitor with dual acetylcholinesterase inhibitory function, mainly used for treating mild to moderate Alzheimer's disease.
Comment(0)
Reason For Report